Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Frontiers in Neurology|February 27, 2024
Feasibility and comparability of different platelet function tests in acute stroke with or without prior antiplatelet therapyJan Hendrik Schaefer, Franziska Lieschke, Hans Urban, et al.Oncoimmunology|December 10, 2020
Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibitionHans Urban, Laurent M Willems, Michael W Ronellenfitsch, et al.Journal of Neuro-Oncology|March 24, 2021
MRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeuticsMaximilian Rauch, Daniel Tausch, Susanne Stera, et al.Cerebellum (London, England)|March 22, 2022
The Acute Superficial Siderosis Syndrome - Clinical Entity, Imaging Findings, and HistopathologyLucie Friedauer, Christian Foerch, Joachim Steinbach, et al.Current Oncology (Toronto, Ont.)|April 21, 2022
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three PatientsAgnes Koch, Stefan Sponholz, Stephan Trainer, et al.Scientific Reports|October 19, 2022
Prevalence of acute neurological complications and pathological neuroimaging findings in critically ill COVID-19 patients with and without VV-ECMO treatmentAngelo Ippolito, Hans Urban, Kimia Ghoroghi, et al.Scientific Reports|July 9, 2021
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomideNadja I Lorenz, Alina C M Sittig, Hans Urban, et al.Acta Neuropathologica Communications|August 22, 2018
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastomaMichael W Ronellenfitsch, Pia S Zeiner, Michel Mittelbronn, et al.Journal of Neurochemistry|November 28, 2017
Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental gliomaJule A Eriksson, Christina Wanka, Michael C Burger, et al.Cell Death Discovery|January 5, 2024
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell deathBenedikt Sauer, Nadja I Lorenz, Iris Divé, et al.Pageof 3